Für Sie gelesen: Head-to-Head, Randomised, Crossover Study of Oral versus Subcutaneous Methotrexate in Patients with Rheumatoid Arthritis: Drug-Exposure Limitations of Oral Methotrexate at Doses >= 15 mg May Be Overcome with Subcutaneous Administration

[摘要]

[学科分类] 生物技术